Senolytic Combination of Dasatinib and Quercetin Promotes Tendon-to-Bone Healing by Mitigating Age-Related Senescence in Rats.

Zhuochang Cai, Haoyuan Wang, Jiacheng Hu, Cheng Qu, Shuai Chen, Xudong Liu, Cunyi Fan

Department of Orthopedics, Shanghai Sixth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China.Department of Orthopedics, Shanghai Sixth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China. · pubmed

Paper

Abstract

An age-dependent increase in cellular senescence has been identified in rotator cuff tears (RCTs). The senolytic combination of dasatinib and quercetin (DQ) has been demonstrated to alleviate musculoskeletal diseases by mitigating age-related senescence. However, the effects of DQ treatment on tendon-to-bone healing remain unknown.

The following analysis is generated by AI and may contain errors. It is separate from the authors’ abstract and is not peer review.

Research summary

The paper claims that the senolytic combination of dasatinib and quercetin promotes tendon-to-bone healing by reducing age-related senescence. This research is relevant as it addresses the underlying mechanisms of cellular senescence, which is a significant contributor to aging and age-related diseases.

Author of this paper? Send a correction.